`
`Glaucoma Treatments - Print Article - MPR
`
`October 13, 2017
`
`Glaucoma Treatments
`
` Download: Glaucoma Treatments
`
`Brand
`
`GLAUCOMA TREATMENTS
`Strength
`Size
`Form
`
`Adult Dose
`
`Generic
`ALPHA2-AGONISTS
`apraclonidine HCl
`
`Iopidine
`
`5mL, 10mL
`
`soln1
`
`0.5%
`5mL, 10mL
`soln1
`brimonidine tartrate Alphagan P
`0.1%, 0.15% 5mL, 10mL, 15mL soln2
`ALPHA2-AGONIST + BETA-BLOCKER
`Combigan
`brimonidine tartrate/
`0.2%/0.5%
`timolol maleate
`BETA-BLOCKERS
`betaxolol HCl
`
`1–2 drops 3 times daily
`
`1 drop every 8hrs
`
`1 drop every 12hrs
`
`1–2 drops twice daily
`
`1–2 drops twice daily
`
`1 drop twice daily
`
`1–2 drops once or twice daily
`
`1 drop twice daily
`
`1 drop twice daily
`
`1 drop once daily in the
`morning
`Initially 1 drop of 0.25% twice
`daily; max 1 drop of 0.5%
`twice daily
`
`1 drop once daily
`
`500mg twice daily
`
`1 drop 3 times daily
`
`1 drop 3 times daily
`
`50–100mg twice to three times
`daily
`
`—
`
`Betoptic S
`
`carteolol HCl
`
`—
`
`levobunolol HCl
`
`Betagan
`
`metipranolol HCl
`
`Optipranolol
`
`timolol hemihydrate Betimol
`
`timolol maleate
`
`Istalol
`
`0.5%
`
`0.25%
`
`1%
`
`0.5%
`
`5mL, 10mL, 15mL soln1
`2.5mL, 5mL,
`susp1
`10mL, 15mL
`5mL, 10mL, 15mL soln1
`5mL, 10mL, 15mL soln1
`0.3%
`5mL, 10mL
`soln1
`0.25%, 0.5% 5mL, 10mL, 15mL soln1
`0.5%
`5mL
`soln1
`
`—
`
`0.25%, 0.5% 5mL, 10mL
`
`Timoptic
`Ocudose
`Timoptic-XE
`
`0.25%, 0.5% 60
`
`0.25%, 0.5% 2.5mL, 5mL
`
`CARBONIC ANHYDRASE INHIBITORS
`Diamox
`acetazolamide
`500mg
`Sequels
`Azopt
`
`brinzolamide
`
`1%
`
`dorzolamide HCl
`
`Trusopt
`
`2%
`
`100
`
`2.5mL, 5mL,
`10mL, 15mL
`10mL
`
`methazolamide
`
`Neptazane
`
`25mg, 50mg
`
`90
`
`soln1
`soln4
`
`gel-
`forming
`soln
`
`sust-rel
`caps
`susp1
`
`soln1
`tabs
`
`NOTES
`Key: soln = solution; sust-rel caps = sustained release capsules; susp = suspension
`Exhibit 1057
`1Contains benzalkonium chloride. May be absorbed by soft contact lenses.
`2Contains purite.
`ARGENTUM
`3Contains sofZia (boric acid, propylene glycol, sorbitol, zinc chloride).
`IPR2017-01053
`4Preservative-free.
`Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact
`company for full drug labeling.
`
`(Rev. 8/2017)
`
`https://www.empr.com/glaucoma-treatments/printarticle/180363/
`
`1/2
`
`000001
`
`
`
`Glaucoma Treatments - Print Article - MPR
`GLAUCOMA TREATMENTS
`Strength
`Size
`Form
`Brand
`Generic
`CARBONIC ANHYDRASE INHIBITOR + ALPHA-AGONIST
`Simbrinza
`brinzolamide/
`1%/0.2%
`8mL
`brimonidine tartrate
`CARBONIC ANHYDRASE INHIBITOR + BETA-BLOCKER
`Cosopt
`2%/0.5%
`10mL
`dorzolamide HCl/
`timolol maleate
`
`4/24/2018
`
`Cosopt PF
`
`2%/0.5%
`
`0.2mL
`
`CHOLINERGIC (MIOTIC) AGONISTS
`Isopto
`15mL
`carbachol
`1.5%
`Carbachol
`15mL, 30mL
`3%
`1%, 2%, 4% 15mL
`
`pilocarpine HCl
`
`Isopto
`Carpine
`
`Pilopine HS
`
`4%
`
`4g
`
`CHOLINESTERASE INHIBITORS
`ecothiophate iodide Phospholine
`Iodide
`
`0.03%, 0.06%,
`0.125%,
`0.25%
`
`5mL
`
`PROSTAGLANDIN ANALOGS
`Lumigan
`bimatoprost
`
`latanoprost
`
`Xalatan
`
`0.01%, 0.03% 2.5mL, 5mL,
`7.5mL
`2.5mL
`
`0.005%
`
`tafluprost
`
`travoprost
`
`Zioptan
`
`0.0015%
`
`0.3mL
`
`Travatan Z
`
`0.004%
`
`2.5mL, 5mL
`
`Adult Dose
`
`1 drop three times daily
`
`1 drop twice daily
`
`2 drops up to 3 times daily
`
`2 drops up to 3–4 times daily
`or more if needed. Heavily
`pigmented irides: need higher
`concentrations.
`Apply ½ inch ribbon in lower
`conjunctival sac at bedtime
`
`0.03% soln instilled twice daily.
`If being transferred due to
`unsatisfactory control with
`pilocarpine, carbachol,
`epinephrine, etc, use higher
`strength soln.
`
`1 drop once daily in the
`evening
`1 drop once daily in the
`evening
`1 drop once daily in the
`evening
`1 drop once daily in the
`evening
`
`1 drop twice daily
`
`susp1
`
`soln1
`soln4
`
`soln1
`
`soln1
`
`gel1
`
`soln
`
`soln1
`
`soln1
`
`soln4
`
`soln3
`
`soln1
`
`PROSTANOIDS (DOCOSANOIDS)
`Rescula
`unoprostone
`isopropyl
`SYMPATHOMIMETICS
`Propine
`dipivefrin HCl
`
`0.15%
`
`5mL
`
`0.1%
`
`5mL, 10mL, 15mL soln1
`
`1 drop every 12hrs
`
`NOTES
`Key: soln = solution; sust-rel caps = sustained release capsules; susp = suspension
`1Contains benzalkonium chloride. May be absorbed by soft contact lenses.
`2Contains purite.
`3Contains sofZia (boric acid, propylene glycol, sorbitol, zinc chloride).
`4Preservative-free.
`Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact
`company for full drug labeling.
`
`(Rev. 8/2017)
`
`This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
`Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions
`
`https://www.empr.com/glaucoma-treatments/printarticle/180363/
`
`2/2
`
`000002
`
`